The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Cardiorenal Syndrome Revisited
Open accessAbstract
Cardiorenal syndromes have been categorized into 5 clinical subtypes based on which organ is perceived to be the primary precipitant of the vicious and interrelated cycle of declining function in both organs. This clinical classification has broadened interest in cardiorenal interactions, but it is merely descriptive, does not rely on or inform predominant pathophysiology, and has produced little change in either practice or the research agenda. In contrast, recent scientific work identifies common pathophysiological pathways for several categories of cardiorenal syndromes, suggesting a unifying pathogenesis. Fibrosis is a common consequence of inflammation- and oxidative stress–related endothelial dysfunction in aging, hypertension, diabetes mellitus, obesity, ischemia, and organ injury. It is a common feature in heart failure and chronic kidney disease. Therefore, we suggest that fibrosis may be not only a marker but also the primary driver of pathophysiology in several cardiorenal syndromes. Interstitial fibrosis in the heart, large arteries, and kidneys may play a key role in the pathophysiology of the cardiorenal syndrome continuum. Focusing on fibrosis as a disease mediator might enable the identification of fibrosis-related biotargets that could potentially be modulated with renin-angiotensin-aldosterone system inhibitors, mineralocorticoid receptor antagonists, or other novel antifibrotic agents in development. This conceptual approach may be an effective new strategy for the prevention and treatment of fibrosis within the cardiorenal syndrome continuum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Self-citationKDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Self-citationEmpagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Self-citationYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Ronco, C., Haapio, M., House, A. A., Anavekar, N., & Bellomo, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.051 · Cited by 1,883
Plasma aldosterone regulation in anephric man
Walker, W. G., & Cooke, C. R. (1973) · Kidney International · doi:10.1038/ki.1973.1 · Cited by 1,841
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Feldman, D., Pamboukian, S. V., Teuteberg, J. J., Birks, E., Lietz, K., Moore, S. A., Morgan, J. A., Arabia, F., Bauman, M. E., Buchholz, H. W., et al. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.09.013 · Cited by 1,368
Williams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., Ford, I., Cruickshank, J. K., Caulfield, M. J., Salsbury, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00257-3 · Cited by 1,308
Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp507 · Cited by 1,104
Pfeffer, M. A., Claggett, B., Assmann, S. F., Boineau, R., Anand, I. S., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., Gordeev, I., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013255 · Cited by 1,065
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306033 · Cited by 1,030
Risk of End-Stage Renal Disease Following Live Kidney Donation
Muzaale, A. D., Massie, A. B., Wang, M.-C., Montgomery, R. A., McBride, M. A., Wainright, J. L., & Segev, D. L. (2014) · JAMA · doi:10.1001/jama.2013.285141 · Cited by 982
Long-term risks for kidney donors
Mjøen, G., Hallan, S., Hartmann, A., Foss, A., Midtvedt, K., Øyen, O., Reisæter, A., Pfeffer, P., Jenssen, T., Leivestad, T., et al. (2014) · Kidney International · doi:10.1038/ki.2013.460 · Cited by 799
Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes.
Makris, K., & Spanou, L. (2016) · PubMed · Cited by 714
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Weir, M. R., Bakris, G. L., Bushinsky, D. A., Mayo, M. R., Garza, D., Stasiv, Y., Wittes, J., Christ-Schmidt, H., Berman, L., & Pitt, B. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410853 · Cited by 669
Maggioni, A. P., Anker, S. D., Dahlström, U., Filippatos, G., Ponikowski, P., Zannad, F., Amir, O., Chioncel, O., Leiro, M. C., Drozdz, J., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft134 · Cited by 667
Self-citationWeight Loss and the Renin-Angiotensin-Aldosterone System
Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F. C., & Sharma, A. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000154361.47683.d3 · Cited by 624
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Ho, J. E., Liu, C., Lyass, A., Courchesne, P., Pencina, M. J., Vasan, R. S., Larson, M. G., & Levy, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.053 · Cited by 589
The kidney in heart failure: an update
Damman, K., & Testani, J. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv010 · Cited by 519
Avosentan for Overt Diabetic Nephropathy
Mann, J. F. E., Green, D., Jamerson, K., Ruilope, L. M., Kuranoff, S. J., Littke, T., & Viberti, G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060593 · Cited by 492
Effects of Intensive BP Control in CKD
Cheung, A. K., Rahman, M., Reboussin, D. M., Craven, T. E., Greene, T., Kimmel, P. L., Cushman, W. C., Hawfield, A. T., Johnson, K. C., Lewis, C. E., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020148 · Cited by 475
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Self-citationPitt, B., Anker, S. D., Bushinsky, D. A., Kitzman, D. W., Zannad, F., Huang, I.-Z., & on behalf of the PEARL-HF Investigators (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq502 · Cited by 438
Self-citationUnderrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease
Coca, S. G., Krumholz, H. M., Garg, A. X., & Parikh, C. R. (2006) · JAMA · doi:10.1001/jama.296.11.1377 · Cited by 408
Ouwerkerk, W., Voors, A. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., ter Maaten, J. M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx026 · Cited by 404
Self-citationBiomarkers in acute kidney injury – pathophysiological basis and clinical performance
Schrezenmeier, E. V., Barasch, J., Budde, K., Westhoff, T., & Schmidt‐Ott, K. M. (2017) · Acta Physiologica · doi:10.1111/apha.12764 · Cited by 401
Myocardial Fibrosis: Biomedical Research from Bench to Bedside
Gyöngyösi, M., Winkler, J., Ramos, I., Do, Q.-T., Firat, H., McDonald, K., González, A., Thum, T., Díez, J., Jaisser, F., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.696 · Cited by 397
Self-citationAhmad, T., Jackson, K., Rao, V. S., Tang, W. H. W., Brisco-Bacik, M. A., Chen, H. H., Felker, G. M., Hernandez, A. F., O’Connor, C. M., Sabbisetti, V. S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030112 · Cited by 360
ter Maaten, J. M., Damman, K., Verhaar, M. C., Paulus, W. J., Duncker, D. J., Cheng, C., van Heerebeek, L., Hillege, H. L., Lam, C. S. P., Navis, G., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.497 · Cited by 320
Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D., & McMurray, J. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3956-x · Cited by 309
Conditional Mineralocorticoid Receptor Expression in the Heart Leads to Life-Threatening Arrhythmias
Ouvrard-Pascaud, A., Sainte-Marie, Y., Bénitah, J.-P., Perrier, R., Soukaseum, C., Cat, A. N. D., Royer, A., Le Quang, K., Charpentier, F., Demolombe, S., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.503706 · Cited by 272
Charytan, D., & Kuntz, R. E. (2006) · Kidney International · doi:10.1038/sj.ki.5001934 · Cited by 271
Bärfacker, L., Kuhl, A., Hillisch, A., Grosser, R., Figueroa‐Pérez, S., Heckroth, H., Nitsche, A., Ergüden, J., Gielen‐Haertwig, H., Schlemmer, K., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200081 · Cited by 270
Testani, J. M., Kimmel, S. E., Dries, D. L., & Coca, S. G. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963256 · Cited by 245
Clinical review: RIFLE and AKIN – time for reappraisal
Cruz, D. N., Ricci, Z., & Ronco, C. (2009) · Critical Care · doi:10.1186/cc7759 · Cited by 242
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Calvier, L., Martinez-Martinez, E., Miana, M., Cachofeiro, V., Rousseau, E., Sádaba, J. R., Zannad, F., Rossignol, P., & López-Andrés, N. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.08.002 · Cited by 215
Self-citationObesity and Kidney Disease: Potential Mechanisms
Wickman, C., & Kramer, H. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.006 · Cited by 213
Brisco, M. A., Zile, M. R., Hanberg, J. S., Wilson, F. P., Parikh, C. R., Coca, S. G., Tang, W. H. W., & Testani, J. M. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.06.423 · Cited by 196
The double challenge of resistant hypertension and chronic kidney disease
Rossignol, P., Massy, Z. A., Azizi, M., Bakris, G., Ritz, E., Covic, A., Goldsmith, D., Heine, G. H., Jager, K. J., Kanbay, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00418-3 · Cited by 194
Self-citationMartínez-Martínez, E., Calvier, L., Fernández-Celis, A., Rousseau, E., Jurado-López, R., Rossoni, L. V., Jaisser, F., Zannad, F., Rossignol, P., Cachofeiro, V., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05876 · Cited by 163
Self-citationRepresentation of Patients With Kidney Disease in Trials of Cardiovascular Interventions
Konstantinidis, I., Nadkarni, G. N., Yacoub, R., Saha, A., Simoes, P. K., Parikh, C. R., & Coca, S. G. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.6102 · Cited by 149
Lattenist, L., Lechner, S. M., Messaoudi, S., Mercier, A. L., Moghrabi, S. E., Prince, S., Bobadilla, N. A., Kolkhof, P., Jaisser, F., & Barrera‐Chimal, J. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08526 · Cited by 146
Terminology and definition of changes renal function in heart failure
Damman, K., Tang, W. H. W., Testani, J., & McMurray, J. J. V. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu320 · Cited by 144
Whaley‐Connell, A. T., & Sowers, J. R. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.034 · Cited by 143
Beldhuis, I. E., Streng, K. W., Ter Maaten, J. M., Voors, A. A., van der Meer, P., Rossignol, P., McMurray, J. J. V., & Damman, K. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003588 · Cited by 126
Self-citationAssociation of Cystatin C With Left Ventricular Structure and Function
Patel, P. C., Ayers, C. R., Murphy, S. A., Peshock, R. M., Khera, A., de Lemos, J. A., Balko, J. A., Gupta, S., Mammen, P. P. A., Drazner, M. H., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.807271 · Cited by 125
Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury
Barrera‐Chimal, J., Pérez‐Villalva, R., Rodríguez‐Romo, R., Reyna, J. C. G., Uribe, N., Gamba, G., & Bobadilla, N. A. (2012) · Kidney International · doi:10.1038/ki.2012.352 · Cited by 122
Lindhardt, M. K., Persson, F., Currie, G. E., Pontillo, C., Beige, J., Delles, C., von der Leyen, H. E., Mischak, H., Navis, G. J., Noutsou, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010310 · Cited by 122
Urbanet, R., Nguyen Dinh Cat, A., Feraco, A., Venteclef, N., El Mogrhabi, S., Sierra-Ramos, C., Alvarez de la Rosa, D., Adler, G. K., Quilliot, D., Rossignol, P., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04981 · Cited by 114
Self-citationCardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors
Moody, W. E., Ferro, C. J., Edwards, N. C., Chue, C. D., Lin, E. L. S., Taylor, R. J., Cockwell, P., Steeds, R. P., & Townend, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06608 · Cited by 106
Tarjus, A., Martínez‐Martínez, E., Amador, C. A., Latouche, C., Moghrabi, S. E., Berger, T., Mak, T. W., Fay, R., Farman, N., Rossignol, P., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05431 · Cited by 105
Self-citationMartínez‐Martínez, E., Buonafine, M., Boukhalfa, I., Ibarrola, J., Fernández‐Celis, A., Kolkhof, P., Rossignol, P., Girerd, N., Mulder, P. G. H., López‐Andrés, N., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09791 · Cited by 92
Self-citationVerbrugge, F. H., Dupont, M., Shao, Z., Shrestha, K. L., Singh, D., Finucan, M., Müllens, W., & Tang, W. H. W. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.07.004 · Cited by 87
Martín, F. L., McKie, P. M., Cataliotti, A., Sangaralingham, S. J., Korinek, J. K., Huntley, B. K., Oehler, E. A., Harders, G. E., Ichiki, T., Mangiafico, S., et al. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00194.2011 · Cited by 84
Cardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches
Ronco, C., & Lullo, L. D. (2016) · Kidney Diseases · doi:10.1159/000448749 · Cited by 78
Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage
Martínez‐Martínez, E., Ibarrola, J., Calvier, L., Fernández‐Celis, A., Leroy, C., Cachofeiro, V., Rossignol, P., & López‐Andrés, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166272 · Cited by 74
Self-citationSokolski, M., Zymliński, R., Biegus, J., Siwołowski, P., Nawrocka‐Millward, S., Todd, J., Yerramilli, M. R., Estis, J., Jankowska, E. A., Banasiak, W., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.746 · Cited by 72
The Effects Of Short-Term Omission of Daily Medication on the Pathophysiology of Heart Failure
Dovancescu, S., Pellicori, P., Mabote, T., Torabi, A., Clark, A. L., & Cleland, J. G. F. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.748 · Cited by 71
Cardiotrophin 1 Is Involved in Cardiac, Vascular, and Renal Fibrosis and Dysfunction
López‐Andrés, N., Rousseau, A., Akhtar, R., Calvier, L., Iñigo, C., Labat, C., Zhao, X., Cruickshank, K. J., Dı́ez, J., Zannad, F. M., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.194407 · Cited by 69
Self-citationEschalier, R., Rossignol, P., Kearney‐Schwartz, A., Adamopoulos, C., Karatzidou, K., Fay, R., Mandry, D., Marie, P., & Zannad, F. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02419 · Cited by 67
Self-citationCooper, L. B., Hammill, B. G., Peterson, E. D., Pitt, B., Maciejewski, M. L., Curtis, L. H., & Hernandez, A. F. (2015) · JAMA · doi:10.1001/jama.2015.11904 · Cited by 63
Rossignol, P., Agarwal, R., Canaud, B., Charney, A., Châtellier, G., Craig, J. C., Cushman, W. C., Gansevoort, R. T., Fellström, B., Garza, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx209 · Cited by 57
Self-citationImpact of Eplerenone on Cardiovascular Outcomes in Heart Failure Patients with Hypokalaemia
Rossignol, P., Girerd, N., Bakris, G. L., Vardeny, O., Claggett, B. L., McMurray, J. J. V., Swedberg, K. B., Krum, H., van Veldhuisen, D. J., Shi, H. H., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.688 · Cited by 50
Self-citationLiu, S., Kompa, A. R., Kumfu, S., Nishijima, F., Kelly, D. J., Krum, H., & Wang, B. H. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.065 · Cited by 46
Cardiovascular Outcome Trials in Patients With Advanced Kidney Disease
Zannad, F. M., & Rossignol, P. (2017) · Circulation · doi:10.1161/circulationaha.117.027338 · Cited by 45
Self-citationInterleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation
Martínez‐Martínez, E., Cachofeiro, V., Rousseau, E., Álvarez, V., Calvier, L., Fernández‐Celis, A., Leroy, C., Miana, M., Jurado-López, R., Briones, A. M., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.007 · Cited by 38
Self-citationPitt, B., & Rossignol, P. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.057 · Cited by 28
Self-citationTargeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure
Weber, K. T., & Díez, J. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003315 · Cited by 26
Rationale of the FIBROTARGETS Study Designed to Identify Novel Biomarkers of Myocardial Fibrosis
Ferreira, J. P., Machu, J., Girerd, N., Jaisser, F., Thum, T., Butler, J., González, A., Dı́ez, J., Heymans, S. R. B., McDonald, K., et al. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12218 · Cited by 26
Self-citationZannad, F. M., Rossignol, P., Stough, W. G., Epstein, M., García, M. D. L. A. A., Bakris, G. L., Butler, J., Kosiborod, M., Berman, L., Mebazaa, A., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.127 · Cited by 25
Self-citationArrieta, V., Martínez‐Martínez, E., Ibarrola, J., Álvarez, V., Sádaba, R., García-Peña, A., Fernández‐Celis, A., Cachofeiro, V., Rossignol, P., & López‐Andrés, N. (2017) · Clinical Science · doi:10.1042/cs20170145 · Cited by 23
Self-citationIs It Time to Evolve Past the Prerenal Azotemia versus Acute Tubular Necrosis Classification?
Belcher, J. M., & Parikh, C. R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08570811 · Cited by 20
Roadmap for cardiovascular prevention trials in chronic kidney disease
Rossignol, P., Pitt, B., Thompson, A., & Zannad, F. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31331-9 · Cited by 17
Self-citationPitt, B., & Rossignol, P. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.746 · Cited by 12
Self-citation
Cited by
Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M., & Bauersachs, J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac223 · Cited by 606
Mullens, W., Damman, K., Testani, J. M., Martens, P., Mueller, C., Lassus, J., Tang, W. H. W., Skouri, H., Verbrugge, F. H., Orso, F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1697 · Cited by 411
Self-citationRossignol, P., Hernandez, A. F., Solomon, S. D., & Zannad, F. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31808-7 · Cited by 316
Self-citationThe Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases
Fontecha-Barriuso, M., Martin-Sanchez, D., Martinez-Moreno, J., Monsalve, M., Ramos, A., Sanchez-Niño, M., Ruiz-Ortega, M., Ortiz, A., & Sanz, A. (2020) · Biomolecules · doi:10.3390/biom10020347 · Cited by 294
Filippatos, G., Anker, S. D., Agarwal, R., Ruilope, L. M., Rossing, P., Bakris, G. L., Tasto, C., Joseph, A., Kolkhof, P., Lage, A., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057983 · Cited by 299
Metadata
- Authors
- Zannad, F., & Rossignol, P.
- Venue
- Circulation
- Published
- 2018-08-28
- Volume
- 138
- Issue
- 9
- Pages
- 929-944
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2889168093
- Cited by
- 335
- References
- 85
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.